Advertisement
There is a high prevalence of financial conflicts of interest among authors of clinical practice guidelines related to high-revenue medications and in gastroenterology

Financial Conflicts of Interest Prevalent Among CPG Authors

0
Two studies show high prevalence among authors of guidelines on high-dollar meds, in gastroenterology
From 2011 to 2015

2011 to 2015 Saw Decline in Health Care-Associated Infections

0
Risk for having a health care-associated infection was 16 percent lower in 2015 than 2011
The American Medical Association (AMA) today announced a new $15 million competitive grant initiative

AMA Announces Initiative to Reinvent Physician Training

0
Competitive grant initiative aims to promote change in graduate medical education
Among top-ranked U.S. hospitals

Many Hospitals Noncompliant With Record Request Regulations

0
Researchers also find discordance in info provided to patients about medical records release processes
For complicated urinary tract infections caused by multidrug-resistant Gram-negative uropathogens

In Complicated UTI, Cefiderocol Noninferior to Imipenem-Cilastin

0
Results from phase 2 study in patients with multidrug-resistant Gram-negative uropathogens
In an effort to cut high drug costs

Trump Administration Announces Plan to Cut Drug Prices

0
HHS study shows Medicare pays 80 percent more than other countries for certain prescription drugs
The impact of alternative payment models on physician practices has been described in a study published by the RAND Corp. and the American Medical Association.

Pace of Change Has Accelerated in Alternative Payment Models

0
Physicians also report increasing complexity of APMs, more financial risk aversion
For patients with acute respiratory failure or shock and hypoactive or hyperactive delirium in the intensive care unit

Neither Haloperidol, Ziprasidone Shortens Delirium in ICU

0
No decrease in duration versus placebo for patients with hypoactive, hyperactive delirium in ICU
For acutely ill patients

Oxygen Saturation Should Not Top 96 Percent in Acutely Ill

0
Patients with acute stroke or MI should not receive supplemental oxygen if SpO2 ≥90 percent
Treatment with myo-inositol for up to 10 weeks does not reduce the risk for type 1 retinopathy of prematurity or death versus placebo for premature infants younger than 28 weeks of gestational age

Myo-Inositol Does Not Reduce Retinopathy of Prematurity

0
No reduction in risk for type 1 ROP or death with myo-inositol versus placebo in preemies <28 weeks